maraviroc (IncellDX/ARISE MD)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namemaraviroc (IncellDX/ARISE MD)
Drug Alias NameCCR5 antagonist (IncellDX's Inc/ARISE MD)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 5 antagonists
TargetsC-C chemokine receptor type 5
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArise
China Registration ClassN/A

Develop Information

Active CompaniesIncellDx IncArise
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A